A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars
Running, not enrolling · Phase 2
Conditions studied: Cicatrix
In brief
The purpose of this study is to compare the effectiveness of the ePrime fractional radiofrequency system to the 1550-nm fractional photothermolysis system (Fraxel) in the ability to improve acne scar appearance.
Key facts
- Study ID
- NCT01976260
- Run by
- Northwestern University
- People needed
- 16
- Starts
- 2013-10-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-07-01
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subjects age 18 years and older.
- Subjects with bilateral 2x2 cm areas of ice pick and/or boxcar acne scars on their face.
- Subjects are in good health.
- Subjects have the willingness and the ability to understand and provide informed consent and communicate with the investigator.
You may not qualify if…
- Subjects who have received injectable soft-tissue augmentation materials to the face, or facial ablative resurfacing, within the past 6 months.
- Subjects who have received injectable botulinum toxin to the face, or any nonablative laser treatment to the face, within the past 3 months.
- Subjects who have local infections, open facial wounds, or other significant local skin disease that would interfere with acne scar treatment with energy devices.
- Subjects who are allergic to lidocaine or prilocaine.
- Subjects who have a history of abnormal scarring in the treatment area, such as keloid scar formation.
- Subjects who have ectropion or or other eyelid disfigurement.
- Subjects who have a history of isotretinoin use in the preceding year.
- Pregnant or lactating individuals.
Where it is running
- Northwestern University Department of Dermatology — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.